Get to Know Alnylam - The Leader in RNAi Therapeutics

Alnylam has pioneered RNAi (RNA interference) therapeutics - an innovative class of medicines which silences the genes that cause or contribute to disease. We're a global and fast growing biopharmaceutical company driven to have a positive impact on the lives of people around the world both with our medicines and our actions outside of the lab. We invite you to learn more at alnylam.com
ALN-CORP-OVV-JAN24